1. Home
  2. AVD vs PMN Comparison

AVD vs PMN Comparison

Compare AVD & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$1.41

Market Cap

72.4M

Sector

Industrials

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

BUY

Current Price

$9.45

Market Cap

84.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AVD
PMN
Founded
1969
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Agricultural Chemicals
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
84.1M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
AVD
PMN
Price
$1.41
$9.45
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $42.52
AVG Volume (30 Days)
★ 300.5K
30.3K
Earning Date
11-09-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 61.11
N/A
EPS
★ N/A
N/A
Revenue
★ $515,114,000.00
N/A
Revenue This Year
$7.74
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.61
$0.29
52 Week High
$5.53
$27.40

Technical Indicators

Market Signals
Indicator
AVD
PMN
Relative Strength Index (RSI) 15.12 33.13
Support Level N/A $9.20
Resistance Level $2.41 $15.37
Average True Range (ATR) 0.10 0.95
MACD -0.03 -0.10
Stochastic Oscillator 4.85 15.55

Price Performance

Historical Comparison
AVD
PMN

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

Share on Social Networks: